Paramount Skydance Appoints Rene Augustine as SVP of Global Public Policy Amid Warner Bros Takeover Battle 
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App 
Sachem Head Boosts Warner Bros. Discovery Stake Amid Netflix Deal and Paramount Bid 
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment 
Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems 
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth 
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions 
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports 
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks 
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act 
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release 
FTC Questions Apple News Over Alleged Bias Against Conservative Media 
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings 
Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth 
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy 
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal 
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth 
WOBURN,Mass., Nov. 06, 2017 -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that the Company plans to release its third quarter 2017 financial results and host a conference call with management after market close on Thursday, November 9, 2017.
Shareholders will participate in the call in listen-only mode. The Company invites shareholders to submit questions for consideration by November 8, 2017 to [email protected] with the subject line: “Questions for Third Quarter 2017 Conference Call.” Questions submitted in advance of the call will be reviewed and some will be addressed in management's prepared remarks or in the Q&A portion of the call.
Interested participants can join the conference call using the following numbers:
U.S. Toll-free dial-in: 1-877-709-8150
International dial-in: 201-689-8354
Event Date/Time: Thursday, November 9 at 4:30 p.m. ET
A live webcast of the call including the slide deck can be accessed through the investor relations section of the Company’s website at www.yield10bio.com. The webcast will be archived on the Company’s website in the investor relations section.
To listen to a telephonic replay of the conference call, dial 877-660-6853 (toll-free) or 201-612-7415 (international) and enter passcode 13672224. The replay will be available for 14 days.
About Yield10
Yield10 Bioscience, Inc. is focused on developing new technologies to achieve step-change improvements in crop yield to enhance global food security. Yield10 has an extensive track record of innovation based around optimizing the flow of carbon in living systems. Yield10 is leveraging its technology platforms and unique knowledge base to design precise alterations to gene activity and the flow of carbon in plants to produce higher yields with lower inputs of land, water or fertilizer. Yield10 is advancing several yield traits it has developed in crops such as Camelina, canola, soybean and corn. Yield10 is headquartered in Woburn, MA and has an Oilseeds center of excellence in Saskatoon, Canada.
For more information about the Company, please visit www.yield10bio.com. (YTEN-E)
Yield10 Inquiries:
Lynne H. Brum, (617) 682-4693, [email protected]
Investor Relations Contact:
Amato and Partners, LLC
90 Park Avenue, 17th Floor
New York, NY 10016
[email protected]
